Risk factors for liver transplantation across the ABO barrier

Transplantation. 1994 Sep 15;58(5):543-7. doi: 10.1097/00007890-199409150-00003.

Abstract

A retrospective study was performed to identify risk factors affecting the fate of liver allografts transplanted across the ABO barrier. Over a 5-year period, 30 patients received 31 emergency OLTs with ABO-incompatible allografts. One-year graft and patient survival rates were 37.1% and 48.4%, respectively. This group was compared with 199 ABO-compatible OLTs performed under similar emergency conditions. Significantly higher incidence of rejection, hepatic artery thrombosis, and biliary stricture were found in ABO-incompatible grafts. The graft or patient survival of patients with O blood group or fulminant hepatic failure was not affected by ABO incompatibility. In contrast, the 1-year survival of recipients with non-O blood group was only 13.3% and the 1-year survival of those undergoing retransplantation was only 27.7% after ABO-incompatible OLT. A multivariate analysis using the Cox proportional hazard model identified non-O blood group (relative risk 3.43) and retransplantation (relative risk 2.46) as the most important risk factors for patient survival after ABO-incompatible OLT. We conclude that the use of ABO-incompatible grafts is justified in emergency cases when no other donor is available, but should be proscribed in patients with non-O blood group. The value of ABO-incompatible grafts in retransplantation is questionable and requires further investigation.

Publication types

  • Comparative Study

MeSH terms

  • ABO Blood-Group System*
  • Adolescent
  • Adult
  • Analysis of Variance
  • Biliary Tract Diseases / etiology
  • Child
  • Child, Preschool
  • Female
  • Follow-Up Studies
  • Graft Rejection / blood
  • Graft Survival / immunology
  • Hepatic Artery
  • Humans
  • Liver Transplantation / adverse effects
  • Liver Transplantation / immunology*
  • Liver Transplantation / mortality
  • Male
  • Retrospective Studies
  • Risk Factors
  • Survival Analysis
  • Thrombosis / etiology

Substances

  • ABO Blood-Group System